Reduced Insulin Exocytosis in Human Pancreatic β-Cells With Gene Variants Linked to Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The majority of genetic risk variants for type 2 diabetes (T2D) affect insulin secretion, but the mechanisms through which they influence pancreatic islet function remain largely unknown. We functionally characterized human islets to determine secretory, biophysical, and ultrastructural features in relation to genetic risk profiles in diabetic and nondiabetic donors. Islets from donors with T2D exhibited impaired insulin secretion, which was more pronounced in lean than obese diabetic donors. We assessed the impact of 14 disease susceptibility variants on measures of glucose sensing, exocytosis, and structure. Variants near TCF7L2 and ADRA2A were associated with reduced glucose-induced insulin secretion, whereas susceptibility variants near ADRA2A, KCNJ11, KCNQ1, and TCF7L2 were associated with reduced depolarization-evoked insulin exocytosis. KCNQ1, ADRA2A, KCNJ11, HHEX/IDE, and SLC2A2 variants affected granule docking. We combined our results to create a novel genetic risk score for β-cell dysfunction that includes aberrant granule docking, decreased Ca2+ sensitivity of exocytosis, and reduced insulin release. Individuals with a high risk score displayed an impaired response to intravenous glucose and deteriorating insulin secretion over time. Our results underscore the importance of defects in β-cell exocytosis in T2D and demonstrate the potential of cellular phenotypic characterization in the elucidation of complex genetic disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“At the time of writing, over 60 genetic loci have been convincingly associated with T2D”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [9]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the great majority in some way involved in β-cell biology, underscoring the importance of β-cell dysfunction in T2D pathogenesis ( 8 , 9 ).”
From β-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment (2014) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This argues that the small (25%) reduction in β-cell/islet insulin content associated with T2DM (576) should not be of major pathophysiological importance and that other functional defects (for example, impaired initiation of electrical activity) are more significant drivers of disease.”
From Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men (2018) · cites this paper as [576]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Transcription Factor 7-Like 2 Regulates β-Cell Survival and Function in Human Pancreatic Islets
Shu, L., Sauter, N. S., Schulthess, F. T., Matveyenko, A. V., Oberholzer, J., & Maedler, K. (2008) · Diabetes · doi:10.2337/db07-0847 · Cited by 265
Retractedβ-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993 · cited 1×
“Rs13266634 (SLC30A8) is the second most strongly associated T2D variant identified to date (1), but previous population studies have shown inconsistent effects of the variant on insulin secretion (31,32).”
BackgroundGenome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
Self-citationThe Wellcome Trust Case Control Consortium, U.K.
Mossman, K. (2008) · Scientific American · doi:10.1038/scientificamerican0108-42a · Cited by 2,684
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287 · cited 1×
“Human islets from donors with the TCF7L2 rs7903146 risk genotype, the genetic variant with the largest effect on T2D susceptibility known to date (20,21), displayed significantly reduced insulin secretion (P = 0.”
BackgroundWellcome Trust Case Control Consortium, Zeggini, E., Scott, L. J., Saxena, R., Voight, B. F., Marchini, J. L., Hu, T., de Bakker, P. I., Abecasis, G. R., Almgren, P., et al. (2008) · Nature Genetics · doi:10.1038/ng.120 · Cited by 1,864
Self-citationTwelve type 2 diabetes susceptibility loci identified through large-scale association analysis
The MAGIC investigators, Voight, B. F., The GIANT Consortium, Scott, L. J., Steinthorsdottir, V., Morris, A. P., Dina, C., Welch, R. P., Zeggini, E., Huth, C., et al. (2010) · Nature Genetics · doi:10.1038/ng.609 · Cited by 1,761
Self-citationGloyn, A. L., Pearson, E. R., Antcliff, J. F., Proks, P., Bruining, G. J., Slingerland, A. S., Howard, N., Srinivasan, S., Silva, J. M. C. L., Molnes, J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032922 · Cited by 1,137 · cited 1×
“Activating mutations in KCNJ11 are a cause of neonatal diabetes (23), and the nonsynonymous rs5219 risk allele of the channel (E23K) combined with the S1369A risk allele of the neighboring ABCC8 (encoding the sulfonylurea receptor 1) exhibits decreased ATP inhibition (24).”
BackgroundSelf-citationInsulin granule dynamics in pancreatic beta cells
Rorsman, P., & Renstr�m, E. (2003) · Diabetologia · doi:10.1007/s00125-003-1153-1 · Cited by 844 · cited 2×
“A current hypothesis postulates that first-phase insulin secretion reflects the release of granules docked beneath the plasma membrane, whereas second phase requires physical recruitment of granules from the cell interior and/or chemical modification (priming) of granules already in place beneath the membrane (16), al…”
BackgroundSelf-citation
Cited by
Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men
Rorsman, P., & Ashcroft, F. M. (2018) · Physiological Reviews · doi:10.1152/physrev.00008.2017 · Cited by 793
Self-citationRegulation of Insulin Secretion in Human Pancreatic Islets
Rorsman, P., & Braun, M. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183754 · Cited by 599
Self-citationUdler, M. S., Kim, J., von Grotthuss, M., Bonàs-Guarch, S., Cole, J. B., Chiou, J., ISGC, C. D. A. O. B. O. M. A. T., Boehnke, M., Laakso, M., Atzmon, G., et al. (2018) · PLOS Medicine · doi:10.1371/journal.pmed.1002654 · Cited by 542
“The loci that clustered most strongly into Cluster 1 include many wellknown beta cell–related loci:MTNR1B,HHEX, TCF7L2, SLC30A8,HNF1A, andHNF1B (Table 1, S3 Table) [60,61].”
BackgroundDayeh, T., Volkov, P., Salö, S., Hall, E., Nilsson, E., Olsson, A. H., Kirkpatrick, C. L., Wollheim, C. B., Eliasson, L., Rönn, T., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004160 · Cited by 523
Self-citationβ-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · Diabetes Care · doi:10.2337/dc14-0396 · Cited by 460
“T2D, the great majority in some way involved in b-cell biology, underscoring the importance of b-cell dysfunction in T2D pathogenesis (8,9).”
BackgroundGenetics of Type 2 Diabetes—Pitfalls and Possibilities
Prasad, R., & Groop, L. (2015) · Genes · doi:10.3390/genes6010087 · Cited by 458
Self-citationIntracellular transport of insulin granules is a subordinated random walk
Tabei, S. M. A., Burov, S., Kim, H. Y., Kuznetsov, A., Huynh, T., Jureller, J., Philipson, L. H., Dinner, A. R., & Scherer, N. F. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1221962110 · Cited by 359
Pancreatic β-cell identity, glucose sensing and the control of insulin secretion
Rutter, G. A., Pullen, T. J., Hodson, D. J., & Martinez-Sanchez, A. (2015) · Biochemical Journal · doi:10.1042/bj20141384 · Cited by 339
MicroRNA-7a regulates pancreatic β cell function
Latreille, M., Hausser, J., Stützer, I., Zhang, Q., Hastoy, B., Gargani, S., Kerr-Conte, J., Pattou, F., Zavolan, M., Esguerra, J. L. S., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73066 · Cited by 281
Self-citationKATP channels and islet hormone secretion: new insights and controversies
Ashcroft, F. M., & Rorsman, P. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.166 · Cited by 272
Self-citationOxidative and endoplasmic reticulum stress in β-cell dysfunction in diabetes
Hasnain, S. Z., Prins, J. B., & McGuckin, M. A. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0232 · Cited by 253
“…dysfunction are an intrinsically linked phenomenon, several lines of evidence, including genetic linkages from genome-wide association studies, have firmly focussed attention on the b-cell as the critical primary contributor to hyperglycaemia in T2D (Ashcroft & Rorsman 2012, Rosengren et al. 2012).”
BackgroundHall, E., Volkov, P., Dayeh, T., Esguerra, J. L. S., Salö, S., Eliasson, L., Rönn, T., Bacos, K., & Ling, C. (2014) · Genome Biology · doi:10.1186/s13059-014-0522-z · Cited by 249
“5% glutaraldehyde in freshly prepared Millonig and post-fixed in 1% osmium tetroxide before being dehydrated and embedded in AGAR 100 (Oxford Instruments Nordiska, Lidingö, Sweden) and cut into ultrathin sections as previously described [81].”
MethodSelf-citationRole of Reduced β-Cell Mass Versus Impaired β-Cell Function in the Pathogenesis of Type 2 Diabetes
Meier, J. J., & Bonadonna, R. C. (2013) · Diabetes Care · doi:10.2337/dcs13-2008 · Cited by 242
“Indeed,glucose-induced insulin secretion in islets taken from patients with type 2 diabetes is reduced by 50% after normalization for islet insulin content, which is a proxy for reduced b-cell number in diabetic islets (74).”
Backgroundβ-Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment
Halban, P. A., Polonsky, K. S., Bowden, D. W., Hawkins, M. A., Ling, C., Mather, K. J., Powers, A. C., Rhodes, C. J., Sussel, L., & Weir, G. C. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1425 · Cited by 222
“involved in β-cell biology, underscoring the importance of β-cell dysfunction in T2D pathogenesis (8, 9).”
BackgroundAcosta, J. R., Douagi, I., Andersson, D. P., Bäckdahl, J., Rydén, M., Arner, P., & Laurencikiene, J. (2016) · Diabetologia · doi:10.1007/s00125-015-3810-6 · Cited by 223
“Although type 2 diabetes in lean individuals is most often linked to beta cell dysfunction [13], an important contributing factor could be impaired expansion of WAT resulting in ectopic fat accumulation.”
BackgroundTCF7L2 is a master regulator of insulin production and processing
Zhou, Y., Park, S.-Y., Su, J., Bailey, K., Ottosson-Laakso, E., Shcherbina, L., Oskolkov, N., Zhang, E., Thevenin, T., Fadista, J., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu359 · Cited by 218
“…glucose-stimulated insulin secretion (GSIS) or other secretagogues like GLP-1(Chang et al., 2010; Loder et al., 2008; Lyssenko et al., 2007; Rosengren et al., 2012; Saxena et al., 2006; Shu et al., 2009; Shu et al., 2008) Risk T-allele carriers are further characterized by an elevated…”
BackgroundInfluentialSelf-citationDayeh, T. A., Olsson, A. H., Volkov, P., Almgren, P., Rönn, T., & Ling, C. (2013) · Diabetologia · doi:10.1007/s00125-012-2815-7 · Cited by 199
Self-citationGrarup, N., Sandholt, C. H., Hansen, T., & Pedersen, O. (2014) · Diabetologia · doi:10.1007/s00125-014-3270-4 · Cited by 201
Metabolic implications of pancreatic fat accumulation
Wagner, R., Eckstein, S. S., Yamazaki, H., Gerst, F., Machann, J., Jaghutriz, B. A., Schürmann, A., Solimena, M., Singer, S., Königsrainer, A., et al. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00573-3 · Cited by 185
Olsson, A. H., Volkov, P., Bacos, K., Dayeh, T., Hall, E., Nilsson, E. A., Ladenvall, C., Rönn, T., & Ling, C. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004735 · Cited by 174
Self-citationVolkov, P., Bacos, K., Ofori, J. K., Esguerra, J. L. S., Eliasson, L., Rönn, T., & Ling, C. (2017) · Diabetes · doi:10.2337/db16-0996 · Cited by 163
“The majority of SNPs associated with T2D impact insulin secretion, supporting their importance in islet function (38).”
BackgroundSelf-citationRfx6 Maintains the Functional Identity of Adult Pancreatic β Cells
Piccand, J., Strasser, P., Hodson, D. J., Meunier, A., Ye, T., Keime, C., Birling, M.-C., Rutter, G. A., & Gradwohl, G. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.11.033 · Cited by 158
“Alterations in both b cell mass (Butler et al., 2003; Marselli et al., 2013; Rahier et al., 2008) and function (Rosengren et al., 2012) are likely to contribute to the overall secretory deficiency observed in type 2 diabetes (Rutter, 2014).”
BackgroundQ&A: insulin secretion and type 2 diabetes: why do β-cells fail?
Cantley, J., & Ashcroft, F. M. (2015) · BMC Biology · doi:10.1186/s12915-015-0140-6 · Cited by 188
Type 2 diabetes: genetic data sharing to advance complex disease research
Flannick, J. A., & Florez, J. C. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.56 · Cited by 173
Monogenic Diabetes: What It Teaches Us on the Common Forms of Type 1 and Type 2 Diabetes
Yang, Y., & Chan, L. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1116 · Cited by 152
Andersson, S. A., Olsson, A. H., Esguerra, J. L. S., Heimann, E., Ladenvall, C., Edlund, A., Salehi, A., Taneera, J., Degerman, E., Groop, L., et al. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.08.009 · Cited by 122
Self-citationTravers, M. E., Mackay, D. J. G., Dekker Nitert, M., Morris, A. P., Lindgren, C. M., Berry, A., Johnson, P. R., Hanley, N., Groop, L. C., McCarthy, M. I., et al. (2013) · Diabetes · doi:10.2337/db12-0819 · Cited by 118
Self-citationZeng, H., Guo, M., Zhou, T., Tan, L., Chong, C. N., Zhang, T., Dong, X., Xiang, J. Z., Yu, A. S., Yue, L., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.07.002 · Cited by 114
Glucose-Dependent Granule Docking Limits Insulin Secretion and Is Decreased in Human Type 2 Diabetes
Gandasi, N. R., Yin, P., Omar-Hmeadi, M., Ottosson Laakso, E., Vikman, P., & Barg, S. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.12.017 · Cited by 115
Locke, J. M., Xavier, G. D. S., Dawe, H. R., Rutter, G. A., & Harries, L. W. (2013) · Diabetologia · doi:10.1007/s00125-013-3089-4 · Cited by 108
“Also consistent with previous findings [13] and with a primary role for reduced GSIS in disease pathogenesis, islets in the replication cohort from individuals with type 2 diabetes displayed reduced glucose-stimulated insulin release when compared with islets from individuals without diabetes (Table 2).”
ResultParacrine control of α-cell glucagon exocytosis is compromised in human type-2 diabetes
Omar-Hmeadi, M., Lund, P.-E., Gandasi, N. R., Tengholm, A., & Barg, S. (2020) · Nature Communications · doi:10.1038/s41467-020-15717-8 · Cited by 105
Antidiabetic Drugs: Mechanisms of Action and Potential Outcomes on Cellular Metabolism
Meneses, M. J., Silva, B. M., Sousa, M., Sá, R., Oliveira, P. F., & Alves, M. G. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150710145753 · Cited by 132
SWELL1 is a glucose sensor regulating β-cell excitability and systemic glycaemia
Chen, K., Xie, L., Gunasekar, S. K., Mishra, A., Zhang, Y., Pai, S., Gao, Y., Kumar, A., Norris, A. W., Stephens, S. B., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02664-0 · Cited by 116
Biology of the KCNQ1 Potassium Channel
Abbott, G. W. (2014) · New Journal of Science · doi:10.1155/2014/237431 · Cited by 115
Thivolet, C., Vial, G., Cassel, R., Rieusset, J., & Madec, A.-M. (2017) · PLOS ONE · doi:10.1371/journal.pone.0182027 · Cited by 97
“Insulin secretion in islets taken from patients with type 2 diabetes is reported to be reduced by 50% after normalization for islet insulin content [12].”
BackgroundKim, H., Westerman, K. E., Smith, K., Chiou, J., Cole, J. B., Majarian, T. D., von Grotthuss, M., Kwak, S. H., Kim, J., Mercader, J. M., et al. (2022) · Diabetologia · doi:10.1007/s00125-022-05848-6 · Cited by 101
“In prior work, the islets were found to have two epigenomic subsets, labelled Beta Table 1 Overview of type 2 diabetes genetic clusters Cluster Expected physiological impact Key top-weighted traits Key top-weighted loci Suspected mechanism Note Beta cell 1 (63) Insulin deficiency CIR (−), DI (−) MTNR1B, CDKAL1, HHEX,…”
BackgroundYe, Y., Barghouth, M., Dou, H., Luan, C., Wang, Y., Karagiannopoulos, A., Jiang, X., Krus, U., Fex, M., Zhang, Q., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-31103-y · Cited by 101
Self-citationKCNQ1 Long QT Syndrome Patients Have Hyperinsulinemia and Symptomatic Hypoglycemia
Torekov, S. S., Iepsen, E., Christiansen, M., Linneberg, A., Pedersen, O., Holst, J. J., Kanters, J. K., & Hansen, T. (2014) · Diabetes · doi:10.2337/db13-1454 · Cited by 84
“Overexpression of KCNQ1 in cultured MIN6 cells decreases both glucose and pyruvate- and tolbutamideinduced insulin secretion (9), and the intronic SNP risk allele of KCNQ1 rs2237895 decreases exocytosis and insulin secretion (1), suggesting that the risk alleles of the intronic KCNQ1 SNPs are gain-of-function polymorp…”
BackgroundResultInfluentialDaneshpajooh, M., Bacos, K., Bysani, M., Bagge, A., Ottosson-Laakso, E., Vikman, P. J., Eliasson, L., Mulder, H., & Ling, C. (2016) · Diabetologia · doi:10.1007/s00125-016-4113-2 · Cited by 84
“Data from genome-wide association studies point towards pancreatic beta cell dysfunction as a key defect causing type 2 diabetes [1].”
Self-citationBysani, M., Agren, R., Davegårdh, C., Volkov, P., Rönn, T., Unneberg, P., Bacos, K., & Ling, C. (2019) · Scientific Reports · doi:10.1038/s41598-019-44076-8 · Cited by 80
The Human Islet: Mini-Organ With Mega-Impact
Walker, J. T., Saunders, D. C., Briššová, M., & Powers, A. C. (2021) · Endocrine Reviews · doi:10.1210/endrev/bnab010 · Cited by 97
Self-citationVarney, M. J., & Benovic, J. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.123.001015 · Cited by 89
“Interest-ingly, studies identified an ADRA2A polymorphism in some individuals that resulted in overexpression of the a 2A AR and impaired glucose-promoted insulin secretion (Rosengren et al., 2010, 2012).”
BackgroundRole of non‐coding RNA s in pancreatic beta‐cell development and physiology
Eliasson, L., & Esguerra, J. L. S. (2014) · Acta Physiologica · doi:10.1111/apha.12285 · Cited by 82
“These include polymorphism in or near the genes of ADRA2a, TCF7L2, KCNJ11 and KCNQ1 (Rosengren et al. 2012) and genes coding for the voltage-sensitive Ca2+ channels (Reinbothe et al. 2013).”
BackgroundSelf-citationIon channels and regulation of insulin secretion in human β-cells: a computational systems analysis
Fridlyand, L. E., Jacobson, D. A., & Philipson, L. H. (2013) · Islets · doi:10.4161/isl.24166 · Cited by 78
“Genome wide association studies have pointed to an association of KCNQ1 with T2 diabetes.(6,71) The voltage-gated potassium channel Kv7.”
BackgroundChen, C., Chmelova, H., Cohrs, C. M., Chouinard, J. A., Jahn, S. R., Stertmann, J., Uphues, I., & Speier, S. (2016) · Diabetes · doi:10.2337/db15-1718 · Cited by 82
“This is in line with the observation that the majority of known T2D susceptibility genes are associated with β-cell function (37).”
ResultGenotype-based treatment of type 2 diabetes with an α2A-adrenergic receptor antagonist
Tang, Y., Axelsson, A. S., Spégel, P., Andersson, L. E., Mulder, H., Groop, L. C., Renström, E., & Rosengren, A. H. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009934 · Cited by 74
“The islets were cultured as previously described (11) at 5.”
BackgroundMethodInfluentialSelf-citationGenetic Determinants for Gestational Diabetes Mellitus and Related Metabolic Traits in Mexican Women
Huerta-Chagoya, A., Vázquez-Cárdenas, P., Moreno-Macías, H., Tapia-Maruri, L., Rodríguez-Guillén, R., López-Vite, E., García-Escalante, G., Escobedo-Aguirre, F., Parra-Covarrubias, A., Cordero-Brieño, R., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0126408 · Cited by 72
TCF7L2 rs7903146 impairs islet function and morphology in non-diabetic individuals
Bacquer, O. L., Kerr-Conte, J. A., Gargani, S., Delalleau, N., Huyvaert, M., Gmyr, V., Froguel, P., NEVE, B. P., & Pattou, F. N. (2012) · Diabetologia · doi:10.1007/s00125-012-2660-8 · Cited by 71
“insulin level and decreased beta cell function in vivo, a recent study reported that carriers of the of TCF7L2 rs7903146 risk allele have reduced insulin secretion compared with those with the non-risk allele [4].”
Satin, L. S., Zhang, Q., & Rorsman, P. (2020) · Diabetes · doi:10.2337/dbi19-0012 · Cited by 78
“The possible significance of these hub or leader cells for diabetes is that if their activity was important for glucoseinduced insulin secretion, their selective dysfunction could in turn contribute to the loss of glucose homeostasis that is a hallmark of type 2 diabetes (12,13).”
BackgroundSelf-citationReinbothe, T. M., Safi, F., Axelsson, A. S., Mollet, I. G., & Rosengren, A. H. (2014) · Islets · doi:10.4161/isl.28095 · Cited by 65
Self-citationMathematical models of electrical activity of the pancreatic β-cell: A physiological review
Félix‐Martínez, G. J., & Godínez-Fernández, J. R. (2014) · Islets · doi:10.4161/19382014.2014.949195 · Cited by 72
Asahara, S.-I., Etoh, H., Inoue, H., Teruyama, K., Shibutani, Y., Ihara, Y., Kawada, Y., Bartolome, A., Hashimoto, N., Matsuda, T., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422104112 · Cited by 63
Beta cell connectivity in pancreatic islets: a type 2 diabetes target?
Rutter, G. A., & Hodson, D. J. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1755-4 · Cited by 67
Collins, S. C., Do, H. W., Hastoy, B., Hugill, A., Adam, J., Chibalina, M. V., Galvanovskis, J., Godazgar, M., Lee, S., Goldsworthy, M. E., et al. (2016) · Diabetes · doi:10.2337/db15-1489 · Cited by 63
Self-citationRoman, T. S., Cannon, M. E., Vadlamudi, S., Buchkovich, M. L., Wolford, B. N., Welch, R. P., Morken, M. A., Kwon, G. J., Varshney, A., Kursawe, R., et al. (2017) · Diabetes · doi:10.2337/db17-0464 · Cited by 61
Nagao, M., Esguerra, J. L. S., Asai, A., Ofori, J. K., Edlund, A., Wendt, A., Sugihara, H., Wollheim, C. B., Oikawa, S., & Eliasson, L. (2020) · Diabetes · doi:10.2337/db19-0944 · Cited by 61
“In fact, increased accumulation of lipid droplets is observed with increased BMI in human b-cells (6).”
BackgroundSelf-citationJiang, S., Shen, D., Jia, W., Han, X., Shen, N., Tao, W., Gao, X., Xue, B., & Li, C. (2015) · The Journal of Pathology · doi:10.1002/path.4652 · Cited by 57
Inhibitory G proteins and their receptors: emerging therapeutic targets for obesity and diabetes
Kimple, M. E., Neuman, J. C., Linnemann, A. K., & Casey, P. J. (2014) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.40 · Cited by 55
Bacos, K., Perfilyev, A., Karagiannopoulos, A., Cowan, E., Ofori, J. K., Bertonnier‐Brouty, L., Rönn, T., Lindqvist, A., Luan, C., Ruhrmann, S., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci163612 · Cited by 57
“Importantly, since many identified risk loci are associated with impaired insulin secretion and/or processes that likely affect β cells (13), these genetic studies convincingly demonstrate that pancreatic islet dysfunction is the key defect in T2D.”
Self-citationZIGIR, a Granule-Specific Zn2+ Indicator, Reveals Human Islet α Cell Heterogeneity
Zadeh, E. H. G., Huang, Z., Xia, J., Li, D., Davidson, H. W., & Li, W.-H. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107904 · Cited by 52
“Tracking the spatial and temporal dynamics of secretory granules has important implications in understanding the mechanisms regulating granule distribution, trafficking, and docking near the plasma membrane, and defects in these cellular processes have been observed in islet cells from diabetic donors (Fu et al., 2019…”
BackgroundKv2.1 Clustering Contributes to Insulin Exocytosis and Rescues Human β-Cell Dysfunction
Fu, J., Dai, X.-Q., Plummer, G., Suzuki, K., Bautista, A., Githaka, J. M., Senior, L., Jensen, M. V., Greitzer-Antes, D., Fox, J. E. M., et al. (2017) · Diabetes · doi:10.2337/db16-1170 · Cited by 58
CHEN, L.-N., LYU, J., YANG, X.-F., JI, W.-J., YUAN, B.-X., CHEN, M.-X., MA, X., & WANG, B. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1453 · Cited by 50
“Islet β cell dysfunction induces insulin secretion disorders and hyperglycemia (33,34).”
The Missing lnc(RNA) between the pancreatic β-cell and diabetes
Kameswaran, V., & Kaestner, K. H. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00200 · Cited by 60
“Frontiers in Genetics | Non-Coding RNA July 2014 | Volume 5 | Article 200 | 4 not correlate with each other (Kong et al., 2009; Voight et al., 2010) and have opposing effects on docking of insulin granules (Rosengren et al., 2012).”
BackgroundTommiska, J., Känsäkoski, J., Skibsbye, L., Vaaralahti, K., Liu, X., Lodge, E. J., Tang, C., Yuan, L., Fagerholm, R., Kanters, J. K., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01429-z · Cited by 49
Micro(RNA) Management and Mismanagement of the Islet
Eliasson, L., & Regazzi, R. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.09.017 · Cited by 52
Self-citationHenquin, J. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101212 · Cited by 55
“Results per islet [193] Deng, 2004 5/5 Peri ramp [29] Doliba, 2012 3/3 Peri [79] Butcher, 2014 5/12 Peri [182] Lundberg, 2018 7/7 Peri [83] Nagao, 2020 49/26 Peri [188] Ostenson, 2006 4/4 Incub [190] Rosengren, 2012 42/17 Incub [191] Locke, 2014 10/10 Incub [194] Batchuluun, 2018 5/5 Incub [195] Solimena, 2018 61/19 I…”
The secretory deficit in islets from db/db mice is mainly due to a loss of responding beta cells
Do, O. H., Low, J. T., Gaisano, H. Y., & Thorn, P. (2014) · Diabetologia · doi:10.1007/s00125-014-3226-8 · Cited by 51
“defects in insulin secretion are important in the disease; an idea supported bywork in humans [6, 7] and in othermodels of type 2 diabetes, such as the Goto-Kakizaki (GK) rat [8, 9].”
BackgroundSox5 regulates beta-cell phenotype and is reduced in type 2 diabetes
Axelsson, A. S., Mahdi, T., Nenonen, H. A., Singh, T., Hänzelmann, S., Wendt, A., Bagge, A., Reinbothe, T. M., Millstein, J., Yang, X., et al. (2017) · Nature Communications · doi:10.1038/ncomms15652 · Cited by 53
Self-citationDNA Methylation Patterning and the Regulation of Beta Cell Homeostasis
Parveen, N., & Dhawan, S. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.651258 · Cited by 50
Chen, X., Green, A. S., Macko, A. R., Yates, D. T., Kelly, A. C., & Limesand, S. W. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00517.2013 · Cited by 50
“NE inhibits insulin secretion via the 2-adrenergic receptors (ARs) in fetal sheep and other species (26, 48, 51, 56).”
BackgroundKCNE3 acts by promoting voltage sensor activation in KCNQ1
Barro-Soria, R., Perez, M. E., & Larsson, H. P. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516238112 · Cited by 55
“1 or KvLQT1) differs from most other Kv channels in that it has key physiological roles in both excitable cells, such as cardiomyocytes (2, 3) and pancreatic β-cells (4, 5), and in nonexcitable cells, such as in epithelia (3, 6).”
BackgroundKindlin-2 modulates MafA and β-catenin expression to regulate β-cell function and mass in mice
Zhu, K., Lai, Y., Cao, H., Bai, X., Liu, C.-J., Yan, Q., Ma, L., Chen, D., Kanaporis, G., Wang, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14186-y · Cited by 50
Verbascoside Protects Pancreatic β-Cells against ER-Stress
Galli, A., Marciani, P., Marku, A., Ghislanzoni, S., Bertuzzi, F., Rossi, R., Giancamillo, A. D., Castagna, M., & Perego, C. (2020) · Biomedicines · doi:10.3390/biomedicines8120582 · Cited by 49
ATP-dependent potassium channels and type 2 diabetes mellitus
Bonfanti, D. H., Alcazar, L. P., Arakaki, P. A., Martins, L. T., Agustini, B. C., Rego, F. G. D. M., & Frigeri, H. R. (2015) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.12.026 · Cited by 47
Somatostatin secretion by Na+-dependent Ca2+-induced Ca2+ release in pancreatic delta cells
Vergari, E., Denwood, G., Salehi, A., Zhang, Q., Adam, J., Alrifaiy, A., Wernstedt Asterholm, I., Benrick, A., Chibalina, M. V., Eliasson, L., et al. (2020) · Nature Metabolism · doi:10.1038/s42255-019-0158-0 · Cited by 43
Self-citationRoles of lncRNAs in pancreatic beta cell identity and diabetes susceptibility
Pullen, T. J., & Rutter, G. A. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00193 · Cited by 44
Do, O. H., Gunton, J. E., Gaisano, H. Y., & Thorn, P. (2016) · Diabetologia · doi:10.1007/s00125-016-3942-3 · Cited by 46
β Cell Dysfunction in Type 2 Diabetes: Drained of Energy?
Knudsen, J. G., & Rorsman, P. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2018.12.015 · Cited by 42
Self-citationDoes Disruption of Circadian Rhythms Contribute to Beta-Cell Failure in Type 2 Diabetes?
Rakshit, K., Thomas, A. P., & Matveyenko, A. V. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0474-4 · Cited by 48
Dayeh, T., & Ling, C. (2015) · Biochemistry and Cell Biology · doi:10.1139/bcb-2015-0057 · Cited by 45
Redox Homeostasis in Pancreatic Cells
Ježek, P., Dlasková, A., & Plecitá‐Hlavatá, L. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/932838 · Cited by 45
“[96] A.”
BackgroundA Role for SPARC in the Moderation of Human Insulin Secretion
Harries, L. W., McCulloch, L. J., Holley, J. E., Rawling, T. J., Welters, H. J., & Kos, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068253 · Cited by 42
“This is noteworthy since polymorphisms in the TCF7L2 gene have been demonstrated in genome wide association studies (GWAS) to show the largest association with susceptibility to type 2 diabetes in several populations [38] and have also been demonstrated to influence insulin exocytosis in human and rodent islets and in…”
BackgroundEvent-based Failure Prediction: An Extended Hidden Markov Model Approach.
Salfner, F. (2008) · Cited by 48
Functional implications of long non-coding RNAs in the pancreatic islets of Langerhans
Esguerra, J. L. S., & Eliasson, L. (2014) · Frontiers in Genetics · doi:10.3389/fgene.2014.00209 · Cited by 41
“Previous studies epigenetic changes in islets from T2D patients correlated with expression of genes involved in insulin secretion (Dayeh et al., 2014).”
BackgroundSelf-citationThe challenge of correctly reporting hormones content and secretion in isolated human islets
Henquin, J. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.10.003 · Cited by 44
Zhao, S., Shi, C. Y., Hu, H., Li, Z., Xiao, G., Yang, Q., Sun, P., Cheng, L., Niu, W., Bi, J., et al. (2019) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2019.111962 · Cited by 41
Neve, B., Bacquer, O. L., Caron, S., Huyvaert, M., Leloire, A., Poulain‐Godefroy, O., Lecœur, C., Pattou, F. N., Staels, B., & Froguel, P. (2014) · Diabetologia · doi:10.1007/s00125-013-3154-z · Cited by 37
The pancreatic β cell: recent insights from human genetics
Thomsen, S. K., & Gloyn, A. L. (2014) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.05.001 · Cited by 41
Self-citationA Century-long Journey From the Discovery of Insulin to the Implantation of Stem Cell–derived Islets
Ramzy, A., Belmonte, P. J., Braam, M. J. S., Ida, S., Wilts, E. M., Levings, M. K., Rezania, A., & Kieffer, T. J. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac021 · Cited by 34
Gut-derived bacterial flagellin induces beta-cell inflammation and dysfunction
Scheithauer, T. P. M., Herrema, H., Yu, H., Bakker, G. J., Winkelmeijer, M., Soukhatcheva, G., Dai, D. L., Ma, C., Havik, S. R., Balvers, M., et al. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2111951 · Cited by 43
“Pancreatic islets from individuals with T2D have lower insulin content compared to healthy controls (Cantley and Ashcroft, 2015; Henquin, 2019; Rahier et al., 2008; Rosengren et al., 2012).”
BackgroundAlam, K. A., Svalastoga, P., Martínez, A., Glennon, J. C., & Haavik, J. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105301 · Cited by 41
“Correspondingly, knockdown of KCNQ1 with siRNA enhances insulin secretion (Rosengren et al., 2012), while overexpression of KCNQ1 in MIN6 cells decreases insulin secretion (Yamagata et al., 2011).”
Every islet matters: improving the impact of human islet research
Gloyn, A. L., Ibberson, M. R., Marchetti, P., Powers, A. C., Rorsman, P., Sander, M., & Solimena, M. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00607-8 · Cited by 37
Self-citationGiannini, C., Man, C. D., Groop, L., Cobelli, C., Zhao, H., Shaw, M. M., Duran, E. J., Pierpont, B. M., Bale, A. E., Caprio, S., et al. (2013) · Diabetes Care · doi:10.2337/dc13-1458 · Cited by 37
Self-citationIslet adaptations in fetal sheep persist following chronic exposure to high norepinephrine
Chen, X., Kelly, A. C., Yates, D. T., Macko, A. R., Lynch, R. M., & Limesand, S. W. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0445 · Cited by 40
Ho, M. M., Yoganathan, P., Chu, K. Y., Karunakaran, S., Johnson, J. D., & Clee, S. M. (2013) · BMC Genetics · doi:10.1186/1471-2156-14-10 · Cited by 41
Udler, M. S., Kim, J., von Grotthuss, M., Bonàs‐Guarch, S., Mercader, J. M., Cole, J. B., Chiou, J., Anderson, C. D., Boehnke, M., Laakso, M., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/319509 · Cited by 32
Bailey, K. A., Savic, D., Zielinski, M. C., Park, S. Y., Wang, L., Witkowski, P., Brady, M., Hara, M., Bell, G. I., & Nóbrega, M. A. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu577 · Cited by 30
Replacing SNAP-25b with SNAP-25a expression results in metabolic disease
Valladolid‐Acebes, I., Daraio, T., Brismar, K., Harkany, T., Ögren, S. O., Hökfelt, T. G. M., & Bark, C. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511951112 · Cited by 32
Davis, M. A., Macko, A. R., Steyn, L. V., Anderson, M. J., & Limesand, S. W. (2015) · Nutrients · doi:10.3390/nu7010500 · Cited by 34
Toward Connecting Metabolism to the Exocytotic Site
Ferdaoussi, M., & MacDonald, P. E. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.10.003 · Cited by 33
Metadata
- Authors
- Rosengren, A. H., Braun, M., Mahdi, T., Andersson, S. A., Travers, M. E., Shigeto, M., Zhang, E., Almgren, P., Ladenvall, C., Axelsson, A. S., Edlund, A., Pedersen, M. G., Jonsson, A., Ramracheya, R., Tang, Y., Walker, J. N., Barrett, A., Johnson, P. R. V., Lyssenko, V., McCarthy, M. I., Groop, L., Salehi, A., Gloyn, A. L., Renström, E., Rorsman, P., & Eliasson, L.
- Affiliations
- Lund University (SE)
- University of Alberta (CA)
- Churchill Hospital (GB)
- Centre for Human Genetics (GB)
- Corresponding author
- Eliasson, Lena
- ORCID
- Rosengren, Anders H.
- Braun, Matthias
- Shigeto, Makoto
- Zhang, Enming
- Almgren, Peter
- Ladenvall, Claes
- Edlund, Anna
- Pedersen, Morten Gram
- Jonsson, Anna
- Ramracheya, Reshma
- Tang, Yunzhao
- Johnson, Paul R.V.
- Lyssenko, Valeriya
- McCarthy, Mark I.
- Groop, Leif
- Salehi, Albert
- Gloyn, Anna L.
- Renström, Erik
- Rorsman, Patrik
- Eliasson, Lena
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2012-06-15
- Volume
- 61
- Issue
- 7
- Pages
- 1726-1733
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC3379663
- OpenAlex
- W2168992353
- Cited by
- 237
- References
- 42
- Citations by year
- 2026: 6 · 2025: 11 · 2024: 6 · 2023: 13 · 2022: 14 · 2021: 10 · 2020: 17 · 2019: 12 · 2018: 8 · 2017: 23 · 2016: 27 · 2015: 27 · 2014: 34 · 2013: 22 · 2012: 6
- FWCI
- 28.99
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Funders
- Wellcome Trust (095101, 095101/Z/10/Z, 095531/Z/11/Z, 090532, 095531)
- Novo Nordisk Fonden (NNF10OC1013350)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- type 2 diabetes, pancreatic beta cells, insulin exocytosis, insulin secretion, genetic risk variants, TCF7L2, ADRA2A, KCNJ11, KCNQ1, GLUT2, granule docking, glucose detection, calcium sensitivity, polygenic risk score, islet ultrastructure
- MeSH terms
- Insulin Secretion, Kcnj11 Channel, Cells, Cultured, Diabetes Mellitus, Type 2, Exocytosis, Humans, Insulin, Transcription Factors, Genetic Variation, Receptors, Adrenergic, alpha-2, Homeodomain Proteins, Genetic Predisposition to Disease, Potassium Channels, Inwardly Rectifying, Insulin-Secreting Cells, Glucose Transporter Type 2, KCNQ1 Potassium Channel, Transcription Factor 7-Like 2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.